We are live on
!
Find out more
PP
PDT Partners Portfolio holdings
AUM
$1.69B
1-Year Est. Return
74.01%
This Fund
S&P 500
This Quarter
Est. Return
+6.28%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.31B
AUM Growth
-$78.9M
(-5.7%)
Cap. Flow
-$105M
Cap. Flow
% of AUM
-7.96%
Top 10 Holdings %
Top 10 Hldgs %
6.88%
Holding
1,081
New
330
Increased
200
Reduced
286
Closed
229
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALLK
Allakos
ALLK
|
+$7.87M |
| 2 |
UiPath
PATH
|
+$6.99M |
| 3 |
Marqeta
MQ
|
+$6.41M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$5.72M |
| 5 |
FIGS
FIGS
|
+$5.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MongoDB
MDB
|
+$7M |
| 2 |
Charles River Laboratories
CRL
|
+$6.37M |
| 3 |
Floor & Decor
FND
|
+$5.83M |
| 4 |
Bruker
BRKR
|
+$5.34M |
| 5 |
Asana
ASAN
|
+$5.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.86% |
| 2 | Healthcare | 21.49% |
| 3 | Industrials | 12.78% |
| 4 | Consumer Discretionary | 11.8% |
| 5 | Financials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
KB Home
KBH
$3.5B
| $318K | 0.02% |
+7,100
| New | +$297K |
|
652
uniQure
QURE
$2.76B
| $317K | 0.02% |
+15,269
| New | +$438K |
|
653
Regeneron Pharmaceuticals
REGN
$72.9B
| $316K | 0.02% |
+500
| New | +$307K |
|
654
Flowers Foods
FLO
$1.58B
| $315K | 0.02% |
+11,484
| New | +$297K |
|
|
OPLN
655
Openlane
OPLN
$4.32B
| $315K | 0.02% |
+20,156
| New | +$309K |
|
656
Allot
ALLT
$364M
| $314K | 0.02% |
26,400
| – | – |
|
657
Enbridge
ENB
$121B
| $313K | 0.02% |
+8,003
| New | +$321K |
|
658
First Interstate BancSystem
FIBK
$3.67B
| $312K | 0.02% |
+7,663
| New | +$318K |
|
|
SEMR
659
DELISTED
Semrush
SEMR
| $312K | 0.02% |
+14,963
| New | +$333K |
|
660
FirstCash
FCFS
$8.78B
| $311K | 0.02% |
+4,151
| New | +$319K |
|
661
HCI Group
HCI
$2.31B
| $310K | 0.02% |
+3,708
| New | +$433K |
|
662
Phibro Animal Health
PAHC
$1.48B
| $310K | 0.02% |
15,200
-3,279
| -18% | -$70K |
|
663
Pultegroup
PHM
$25.3B
| $308K | 0.02% |
+5,390
| New | +$276K |
|
|
AMK
664
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $307K | 0.02% |
11,700
-2,254
| -16% | -$58.3K |
|
|
IBTX
665
DELISTED
Independent Bank Group, Inc.
IBTX
| $306K | 0.02% |
+4,248
| New | +$307K |
|
666
Innoviva
INVA
$1.59B
| $305K | 0.02% |
+17,699
| New | +$302K |
|
|
CYBE
667
DELISTED
Cyberoptics Corp
CYBE
| $304K | 0.02% |
6,542
-3,119
| -32% | -$130K |
|
668
Ironwood Pharmaceuticals
IRWD
$598M
| $299K | 0.02% |
+25,675
| New | +$315K |
|
669
Astronics
ATRO
$3.27B
| $298K | 0.02% |
29,792
+32
| +0.1% | +$336 |
|
670
Cogent Communications
CCOI
$603M
| $296K | 0.02% |
+4,048
| New | +$304K |
|
671
Kura Oncology
KURA
$788M
| $295K | 0.02% |
+21,060
| New | +$341K |
|
|
AGS
672
DELISTED
PlayAGS
AGS
| $294K | 0.02% |
43,348
+7,898
| +22% | +$60.5K |
|
673
LCI Industries
LCII
$2.59B
| $294K | 0.02% |
1,887
-2,413
| -56% | -$359K |
|
|
VBTX
674
DELISTED
Veritex Holdings
VBTX
| $292K | 0.02% |
+7,344
| New | +$298K |
|
675
Anika Therapeutics
ANIK
$217M
| $291K | 0.02% |
8,128
-8,381
| -51% | -$335K |
|
Similar funds
ISS
GAM
BCM
FACM
TCBWMS
SGI
AAM
RSCM
PDT Partners's Q4 2021 Portfolio in Review
As of Q4 2021, PDT Partners held 1,081 positions worth $1.31B, down 5.7% from $1.39B the previous quarter. Its ten largest holdings account for 6.9% of the portfolio.
PDT Partners withdrew a net $105M in Q4 2021, closing 229 positions and reducing 286 holdings. Its most notable exit was MongoDB, an estimated $7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, PDT Partners opened a new position in Allakos worth $940K.
- PDT Partners's largest Q4 2021 buy was Allakos: 96,046 shares worth $940K.
- PDT Partners added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021, an estimated $5.72M increase.
- PDT Partners's biggest Q4 2021 reduction was Charles River Laboratories, cutting an estimated $6.37M.
- PDT Partners fully exited MongoDB in Q4 2021, selling an estimated $7M.
- PDT Partners's ten largest holdings make up 6.9% of its $1.31B portfolio in Q4 2021.
- PDT Partners opened 330 new positions and closed 229 in Q4 2021.
- PDT Partners's portfolio value fell 5.7% quarter-over-quarter to $1.31B.
Based on PDT Partners's 13F filing for Q4 2021, filed 14 Feb 2022.